MiNK Therapeutics, Inc. (INKT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 36.07K | 38.56K | 43.65K | 48.76K | 50.77K | 53.87K | 62.64K | 45.1K | 53.83K | 53.57K | 53.45K | 51.91K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -36.07K | -38.56K | -43.65K | -48.76K | -50.77K | -53.87K | -62.64K | -45.1K | -53.83K | -53.57K | -53.45K | -51.91K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 28.95% | 28.41% | 30.31% | -8.12% | 5.7% | -0.55% | -17.18% | 13.11% | -17.83% | -41.23% | -88.02% | -83.36% |
| Operating Expenses | 2.85M | 3.24M | 2.95M | 3.64M | 2.48M | 2.16M | 1.64M | 2.86M | 3.78M | 5.45M | 5.17M | 6.29M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.68B | 6.72B | 1.8M | 1.85M | 1.22M | 755.13K | 1.1M | 1.02M | 1.23M | 2.14M | 1.74M | 1.73M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.2B | 5.75B | 1.14M | 1.84M | 1.26M | 1.41M | 540.64K | 1.84M | 2.55M | 3.31M | 3.43M | 4.56M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | -1000K | 0 | -48.76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.88M | -3.28M | -2.99M | -3.69M | -2.53M | -2.21M | -1.7M | -2.9M | -3.83M | -5.5M | -5.22M | -6.34M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -13.78% | -47.93% | -75.48% | -27.11% | 33.87% | 59.73% | 67.38% | 54.26% | 34.58% | 30.28% | 34.6% | 17.6% |
| EBITDA | -2.85M | -3.24M | -2.95M | -3.64M | -2.48M | -2.16M | -1.64M | -2.86M | -3.78M | -5.45M | -5.17M | -6.29M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -14.65% | -49.83% | -79.52% | -27.41% | 34.27% | 60.32% | 68.26% | 54.6% | 34.99% | 30.63% | 35.04% | 17.97% |
| D&A (Non-Cash Add-back) | 36.07K | 38.56K | 43.65K | 48.76K | 50.77K | 53.87K | 62.64K | 45.1K | 53.83K | 53.57K | 53.45K | 51.91K |
| EBIT | -2.88M | -2.6M | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M |
| Net Interest Income | 80.83K | -69.02K | 55.15K | 348 | 13.52K | 39.57K | 78.02K | 38.36K | 16.62K | 41.52K | 107.29K | 146.39K |
| Interest Income | 80.83K | -69.02K | 55.15K | 348 | 13.52K | 39.57K | 78.02K | 38.36K | 16.62K | 41.52K | 107.29K | 146.39K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 139.42K | 674.46K | 101.96K | -549.45K | -233.93K | -249K | -102.93K | 199.86K | 16.62K | 41K | 107.3K | 146.39K |
| Pretax Income | -2.74M | -2.6M | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.74M | -2.6M | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.88% | -5.6% | -59.84% | -56.85% | 27.45% | 54.86% | 64.69% | 56.4% | 32.94% | 29.73% | 19.2% | -1.38% |
| Net Income (Continuing) | -2.74M | -2.6M | -2.89M | -4.24M | -2.77M | -2.46M | -1.81M | -2.7M | -3.81M | -5.46M | -5.12M | -6.2M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.57 | -0.55 | -0.65 | -1.06 | -0.70 | -0.65 | -0.46 | -0.73 | -1.10 | -1.58 | -1.48 | -1.80 |
| EPS Growth % | 18.57% | 15.38% | -41.3% | -45.21% | 36.36% | 58.86% | 68.92% | 59.44% | -102.3% | 28.18% | -5.71% | -38.46% |
| EPS (Basic) | -0.57 | -0.55 | -0.65 | -1.06 | -0.70 | -0.65 | -0.48 | -0.73 | -1.10 | -1.58 | -1.48 | -1.80 |
| Diluted Shares Outstanding | 4.8M | 4.27M | 4.44M | 3.98M | 3.96M | 3.77M | 3.95M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M |
| Basic Shares Outstanding | 4.8M | 4.27M | 4.44M | 3.98M | 3.96M | 3.77M | 3.74M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |